Extension to the AzureSeq-200 CE One-step RT-qPCR Assay

26/03/2021

Omixon and SeqOnce Biosciences Announce an Extension to the AzureSeq-200 CE One-step RT-qPCR Assay to Detect SARS-CoV-2 E484K N501Y mutations and K417 wildtype Assay quickly identifies the E484K, N501Y mutations and K417 wildtype found in U.K., South Africa, and Brazil lineages of SARS-CoV-2 Transplantation was severely affected by the...

Omixon Launches AzureSeq-200 CE IVD Kit For One-step RT-qPCR Detection of SARS-CoV-2 and Announces Exclusive Agreement with SeqOnce Biosciences

05/10/2020

As much as Omixon wants to stay focused on the needs of histocompatibility labs, the current coronavirus pandemic calls for innovation in the field of viral detection based on molecular diagnostics. Omixon has used its product development capabilities and collaboration network to develop a truly innovative product addressing an...

Webinar – COVID-19 and HLA: The Current State of Knowledge and Future Directions

12/08/2020

The SARS-CoV-2 pandemic has become one of the most serious public health issues. The adaptive immune system has a fundamental role in the recognition and destruction of the virus. Join us for a webinar with Máté Manczinger (Project Leader at Csaba Pál Laboratory, Biological Research Centre, Szeged, Hungary)...